Education
About Us
Working with TipRanks
Follow Us
Proteomics International Laboratories Ltd. (AU:PIQ)
ASX:PIQ
RESEARCH TOOLSreports
Total Valuation
Proteomics International Laboratories Ltd. has a market cap or net worth of AU$52.47M. The enterprise value is AU$108.70M.
Market CapAU$52.47M
Enterprise ValueAU$108.70M
Share Statistics
Proteomics International Laboratories Ltd. has 141,813,520 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding141,813,520
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Proteomics International Laboratories Ltd.’s return on equity (ROE) is -0.68 and return on invested capital (ROIC) is -68.02%.
Return on Equity (ROE)-0.68
Return on Assets (ROA)-0.59
Return on Invested Capital (ROIC)-68.02%
Return on Capital Employed (ROCE)-0.92
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.08
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Proteomics International Laboratories Ltd. is -17.17. Proteomics International Laboratories Ltd.’s PEG ratio is 3.28.
PE Ratio-17.17
PS Ratio0.00
PB Ratio11.63
Price to Fair Value11.63
Price to FCF-18.26
Price to Operating Cash Flow-19.58
PEG Ratio3.28
Income Statement
In the last 12 months, Proteomics International Laboratories Ltd. had revenue of 892.14K and earned -6.38M in profits. Earnings per share was -0.05.
Revenue892.14K
Gross Profit-1.12M
Operating Income-9.12M
Pretax Income-8.64M
Net Income-6.38M
EBITDA-8.40M
Earnings Per Share (EPS)-0.05
Cash Flow
In the last 12 months, operating cash flow was -5.46M and capital expenditures -46.19K, giving a free cash flow of -5.51M billion.
Operating Cash Flow-5.46M
Free Cash Flow-5.51M
Free Cash Flow per Share-0.04
Dividends & Yields
Proteomics International Laboratories Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.69
52-Week Price Change-64.71%
50-Day Moving Average0.46
200-Day Moving Average0.66
Relative Strength Index (RSI)32.99
Average Volume (3m)110.54K
Important Dates
Proteomics International Laboratories Ltd. upcoming earnings date is Sep 2, 2025, TBA Not Confirmed.
Last Earnings DateFeb 25, 2025
Next Earnings DateSep 2, 2025
Ex-Dividend Date―
Financial Position
Proteomics International Laboratories Ltd. as a current ratio of 10.13, with Debt / Equity ratio of 4.54%
Current Ratio10.13
Quick Ratio10.13
Debt to Market Cap0.00
Net Debt to EBITDA0.75
Interest Coverage Ratio-393.70
Taxes
In the past 12 months, Proteomics International Laboratories Ltd. has paid -2.16M in taxes.
Income Tax-2.16M
Effective Tax Rate0.25
Enterprise Valuation
Proteomics International Laboratories Ltd. EV to EBITDA ratio is -12.29, with an EV/FCF ratio of -17.20.
EV to Sales115.64
EV to EBITDA-12.29
EV to Free Cash Flow-17.20
EV to Operating Cash Flow-18.44
Balance Sheet
Proteomics International Laboratories Ltd. has AU$5.33M in cash and marketable securities with ― in debt, giving a net cash position of -AU$5.08M billion.
Cash & Marketable SecuritiesAU$5.33M
Total Debt―
Net Cash-AU$5.08M
Net Cash Per Share-AU$0.04
Tangible Book Value Per ShareAU$0.07
Margins
Gross margin is 41.64%, with operating margin of -1022.79%, and net profit margin of -714.71%.
Gross Margin41.64%
Operating Margin-1022.79%
Pretax Margin-968.25%
Net Profit Margin-714.71%
EBITDA Margin-941.23%
EBIT Margin-1022.79%
Analyst Forecast
The average price target for Proteomics International Laboratories Ltd. is AU$0.43, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price TargetAU$0.43
Price Target Upside19.44% Upside
Analyst ConsensusModerate Sell
Analyst Count1
Revenue Growth Forecast12.53%
EPS Growth Forecast-11.04%